US › Healthcare

ReWalk Robotics Ltd (LFWD)

US · Healthcare · Medical Devices

$7.21-0.14%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$3.9M
Revenue YoY
-22.1%
Net profit
$-10.8M
Profit YoY
-123.3%
EPS
$-6.70
EPS estimate
$-0.34
Net margin
-275.1%

EPS came in at -6.70 against a street estimate of -0.34 — a miss of 1870.6%.

Key statistics

Market cap
$20.3M
Forward P/E
0.0
P/B
3.23
Book value
$2.26
EPS (TTM)
$-18.33
52-week high
$10.56
52-week low
$4.14
50-day MA
$7.37
200-day MA
$7.19
Beta
0.37

Analyst view

Analysts rate ReWalk Robotics Ltd a buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $20.00.

Shareholding

Insiders
47.45%
Institutions
0.79%

Largest institutional holders

FundStake
Renaissance Technologies Corp0.75%
UBS Group AG0.14%
Morgan Stanley - Brokerage Accounts0.01%
SBI Securities Co Ltd0.01%
Advisor Group Holdings, Inc.0.01%
NATIONAL BANK OF CANADA /FI/0.00%
Caitong International Asset Management Co., Limited.0.00%
Group One Trading, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for ReWalk Robotics Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.